LivaNova (LIVN) Cash from Investing Activities (2015 - 2026)
LivaNova (LIVN) posted Cash from Investing Activities of -$14.6 million for Q1 2026, up 51.82% sequentially from -$30.3 million in Q4 2025, and down 37.18% YoY from -$23.2 million in Q1 2025.
LivaNova (LIVN) Cash from Investing Activities (2015 - 2026) Analysis & Trends
LivaNova has reported Cash from Investing Activities for 12 years, with the latest figure at -$14.6 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 37.18% year-over-year to -$14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.9 million (down 46.62% YoY) and the FY2025 annual result came in at -$72.9 million, down 51.4% from the prior year.
- Cash from Investing Activities grew to -$14.6 million in Q1 2026 per LIVN's latest filing, from -$30.3 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$5.5 million in Q1 2022 and troughed at -$30.3 million in Q4 2025.
- A 5-year average of -$12.6 million and a median of -$11.0 million in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities slumped 201.65% in 2022, then soared 58.79% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$11.0 million in 2022, then slipped by 10.82% to -$12.1 million in 2023, then advanced by 11.78% to -$10.7 million in 2024, then slumped by 182.58% to -$30.3 million in 2025, then soared by 51.82% to -$14.6 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$14.6 million, -$30.3 million, and -$23.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | -108.50 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -31.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.92 Mn |
| Jun 30, 2026 | -31.92 Mn |
| Mar 31, 2026 | -14.58 Mn |
| Mar 31, 2026 | -14.58 Mn |
| Dec 31, 2025 | -30.26 Mn |
| Dec 31, 2025 | -30.26 Mn |
| Sep 30, 2025 | -23.06 Mn |
| Sep 30, 2025 | -23.06 Mn |
| Jun 30, 2025 | -8.97 Mn |
| Jun 30, 2025 | -8.97 Mn |
| Mar 31, 2025 | -10.63 Mn |
| Mar 31, 2025 | -10.63 Mn |
| Dec 31, 2024 | -10.71 Mn |
| Dec 31, 2024 | -10.71 Mn |
| Sep 30, 2024 | -18.52 Mn |
| Sep 30, 2024 | -18.52 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Jun 30, 2024 | -12.57 Mn |
| Mar 31, 2024 | -6.36 Mn |
| Mar 31, 2024 | -6.36 Mn |